Second-Line Chemotherapy for Non–Small-Cell Lung Cancer: Recent Data with Pemetrexed-Reference-Cited by-同舟云学术

Second-Line Chemotherapy for Non–Small-Cell Lung Cancer: Recent Data with Pemetrexed

Published:2004-04 Issue: Volume:5 Page:S75-S79
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Hanna Nasser H.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Cancer Statistics, 2004;Jemal;CA Cancer J Clin,2004

2. The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting;Stephens;Proc Am Soc Clin Oncol,2002

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-small Cell Lung Cancer Collaborative Group;BMJ,1995

4. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?;Grilli;J Clin Oncol,1993

5. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in monotherapy and combination therapy of S-1 for patients with advanced non-small cell lung cancer: a narrative review;Translational Cancer Research;2024-04

2. A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER;Frontiers in Oncology;2020-10-26

3. Pharmacogenomics in Lung Cancer;IASLC Thoracic Oncology;2018

4. Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies;PLOS ONE;2017-04-14

5. Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells;Regulatory Toxicology and Pharmacology;2016-11